Alnylam Pharmaceuticals
ALNY
#868
Rank
NZ$49.75 B
Marketcap
NZ$371.83
Share price
1.43%
Change (1 day)
-49.50%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company